Mobile

A study to test two investigational drugs, dabrafenib and trametinib, in combination together for treating a specific type of melanoma compared to another drug, vemurafenib that is approved for treati...

Mise à jour : Il y a 4 ans
Référence : EUCTR2011-006088-23

A study to test two investigational drugs, dabrafenib and trametinib, in combination together for treating a specific type of melanoma compared to another drug, vemurafenib that is approved for treatingthe same type of melanoma

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

• To establish the superiority of dabrafenib and trametinib combination therapy with vemurafenib monotherapy with respect to overall survival (OS) for subjects with advanced/metastatic BRAF V600E/K mutation-positive cutaneous melanoma.

Critère d'inclusion

  • Metastatic melanoma

Liens